RxSight, Inc. — Company profile
Healthcare · Medical Devices · United States
Last price 5.05 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 210.05M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
RxSight, Inc., a commercial-stage medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company’s RxSight system includes RxSight Light Adjustable Lens (LAL), an intraocular lens made of photosensitive material that changes shape in response to specific patterns of ultraviolet, which can be adjusted to improve uncorrected visual acuity; and RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. RxSight, Inc. was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. The company was incorporated in 1997 and is headquartered in Aliso Viejo, California.
Details
| Name | RxSight, Inc. |
| Sector | Healthcare |
| Industry | Medical Devices |
| Employees | 461 |
| Founded | 1997 |
| Ipo Date | 2021-07-30 |
| Ceo | Aziz Mottiwala |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Ipo Price | 16.00 |
| Isin | US78349D1072 |
| Cusip | 78349D107 |
| Cik | 1111485 |
| Sic | 3851 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| Aziz Mottiwala M.B.A. | President, Chief Executive Officer and Director |
| Dr. Ilya Goldshleger Ph.D. | Chief Operating Officer |
| Eric J. Weinberg | Chief Business Development Officer |
| Dr. Ronald M. Kurtz M.D. | Chief Medical Officer |
| Mark Wilterding | Chief Financial Officer |
| Oliver Moravcevic | Vice President of Investor Relations |
| Jim Schindler | Executive Vice President and General Counsel |
Contact
| Address | 100 Columbia, Aliso Viejo, California 92656, United States |
| Phone | 949 521 7830 |
| Website | https://rxsight.com |